1. Academic Validation
  2. Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia

Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia

  • Prog Neuropsychopharmacol Biol Psychiatry. 1994 Mar;18(2):339-46. doi: 10.1016/0278-5846(94)90065-5.
M Kuniyoshi 1 J Nakamura C Miura K Inanaga
Affiliations

Affiliation

  • 1 Chikusuikai Hospital, Chikusuikai Institute for Neuroinformation, Yame-city, Japan.
Abstract

1. Setiptiline maleate was administered to schizophrenic patients with the object of improving their negative symptoms. 2. Moderate improvements were observed in 58% of the treated patients, thus usefulness of this drug was demonstrated. 3. There was no aggravation of symptoms, and side effects were minor. 4. Measurements of plasma monoamine metabolites showed a tendency of MHPG to decrease and a significant decrease in 5-HIAA, but no change in the level of HVA was observed, suggesting a relationship between the negative symptoms and noradrenaline and/or serotonin systems.

Figures
Products